Pregnancy Clinical Trial
Official title:
Fetal Spina Bifida -Prenatal Course and Outcome in 103 Cases A Single Center Experience.
Verified date | May 2018 |
Source | University of Luebeck |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Neural tube defects are one of the most prevalent congenital abnormalities, surpassed only by
cardiac malformations. Spina bifida accounts for the majority of the neural tube defects and
is comprised of a wide spectrum of anomalies ranging from small isolated sacral dysraphisms
to large spinal defects. The origin of spina bifida is a failure of neurulation. It usually
occurs at 15 days post-conception, resulting in a bony spinal defect with extrusion of the
neural placode and/or the meninges outside of the spinal canal. Spina bifida has a prevalence
of 1-5 in 1,000 live births and is the most complex congenital abnormality compatible to
long-time survival. Concerning psychomotor development as well as urinary bladder and
intestinal morbidity the prognosis ranges from normal functional outcome to severe
disability.
The diagnosis of serious fetal abnormalities such as spinal dysraphism by ultrasound
screening allows patients to prepare for the birth of an impaired child or to consider
termination of the pregnancy. In current practice, prenatal counseling and obstetric
management depend not only on the detection of a spinal dysraphism but also on an appropriate
assessment of the severity of the defect and its possible impact on the postnatal development
of the affected child.
Level and type of lesion, presence of associated anomalies (e.g., Chiari II malformation and
ventriculomegaly) and mode of surgical closure are factors known to have prognostic impact on
the postnatal outcome. Previous studies reported that postnatally determined lesion levels
correlated well with functional status and survival. On the contrary, it is still not clear
whether similar data obtained antenatally are of value.
In this study, the investigators will review their database of all cases of prenatally
diagnosed spina bifida within a 16 year period between 1993 and 2009. By analyzing the
prenatal and postnatal characteristics of fetuses with spina bifida in relation to the
anatomic level of the lesion, the investigators aim to contribute further information
regarding the natural course of affected pregnancies and the correlation of prenatal
ultrasound findings with their functional outcome.
Status | Completed |
Enrollment | 103 |
Est. completion date | October 1, 2015 |
Est. primary completion date | October 2014 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 12 Weeks to 12 Years |
Eligibility |
Inclusion Criteria: - spina bifida identified at prenatal ultrasound examination - ultrasound diagnosis between 1993 - 2009 Exclusion Criteria: - deviant postnatal diagnosis - loss to follow-up - incomplete data |
Country | Name | City | State |
---|---|---|---|
Germany | Schleswig- Holstein University, Campus Lübeck, Department of Prenatal Medicine | Lübeck | Schleswig- Holstein |
Lead Sponsor | Collaborator |
---|---|
University of Luebeck |
Germany,
Biggio JR Jr, Owen J, Wenstrom KD, Oakes WJ. Can prenatal ultrasound findings predict ambulatory status in fetuses with open spina bifida? Am J Obstet Gynecol. 2001 Nov;185(5):1016-20. — View Citation
Cameron M, Moran P. Prenatal screening and diagnosis of neural tube defects. Prenat Diagn. 2009 Apr;29(4):402-11. doi: 10.1002/pd.2250. Review. — View Citation
D'Addario V, Rossi AC, Pinto V, Pintucci A, Di Cagno L. Comparison of six sonographic signs in the prenatal diagnosis of spina bifida. J Perinat Med. 2008;36(4):330-4. doi: 10.1515/JPM.2008.052. — View Citation
Peralta CF, Bunduki V, Plese JP, Figueiredo EG, Miguelez J, Zugaib M. Association between prenatal sonographic findings and post-natal outcomes in 30 cases of isolated spina bifida aperta. Prenat Diagn. 2003 Apr;23(4):311-4. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | pregnancy outcome | To investigate the prenatal course and functional outcome of fetuses with spina bifida according to prenatal ultrasound exam. | 17 yrs | |
Primary | Infant psychomotor development | Kaufmann ABC Denver Developmental Screening Test walking ability muscle strenght |
17 yrs | |
Primary | Infant bladder and bowel function | Degree of continence. | 17 yrs | |
Secondary | Conception date | 17 yrs | ||
Secondary | spectrum of ultrasound signs | 17yrs |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03442582 -
Afluria Pregnancy Registry
|
||
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Enrolling by invitation |
NCT05415371 -
Persistent Poverty Counties Pregnant Women With Medicaid
|
N/A | |
Completed |
NCT04548102 -
Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman
|
N/A | |
Completed |
NCT03218956 -
Protein Requirement During Lactation
|
N/A | |
Completed |
NCT02191605 -
Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy
|
N/A | |
Completed |
NCT02223637 -
Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
|
||
Recruiting |
NCT06049953 -
Maternal And Infant Antipsychotic Study
|
||
Completed |
NCT02577536 -
PregSource: Crowdsourcing to Understand Pregnancy
|
||
Not yet recruiting |
NCT06336434 -
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT05412238 -
Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months
|
N/A | |
Not yet recruiting |
NCT04786587 -
Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
|
||
Not yet recruiting |
NCT05028387 -
Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
|
||
Completed |
NCT02683005 -
Study of Hepatitis C Treatment During Pregnancy
|
Phase 1 | |
Completed |
NCT02783170 -
Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women
|
Phase 4 | |
Recruiting |
NCT02507180 -
Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
|
||
Recruiting |
NCT02564250 -
Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women
|
N/A | |
Recruiting |
NCT02619188 -
Nutritional Markers in Normal and Hyperemesis Pregnancies
|
N/A | |
Completed |
NCT02408315 -
Induction With Misoprostol: Oral Mucosa Versus Vaginal Epithelium (IMPROVE)
|
Phase 3 |